RNXT Stock Analysis: Buy, Sell, or Hold?
RNXT - RenovoRx, Inc. Common Stock
$0.84
-0.02 (-2.41%)
▼
5d:
-3.23%
30d:
-0.57%
90d:
+1.04%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When RNXT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RNXT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RNXT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RNXT is currently trading at $0.84, which is considered slightly low relative to its 30-day fair value range of $0.83 to $0.92.
Technical Outlook: Technically, RNXT is in a downtrend. The price is currently testing key support at $0.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RNXT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.03 (+733.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RNXT is in a downtrend. The price is currently testing key support at $0.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RNXT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.03 (+733.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.83 -
$0.92
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 733.1% below Wall St target ($7.03)
Trading Range Analysis
30-Day Trading Range
$0.83 -
$0.92
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.85
Resistance Level
$0.99
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.63
Wall Street Target
$7.03
(+733.1%)
Revenue Growth (YoY)
185.8%
Share & Embed Analysis
Last updated: June 15, 2026 5:44 AM ET
Data refreshes hourly during market hours. Next update: 6:44 AM
Data refreshes hourly during market hours. Next update: 6:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNXT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ramtin Agah
BUY
10000 shares
2026-01-21
Ramtin Agah
BUY
9795 shares
2025-12-31
Ramtin Agah
BUY
205 shares
2025-12-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 49 HOLD |
